Myosana Therapeutics

company

About

Myosana Therapeutics is a new biotech company developing novel platform technology for non-viral gene delivery.

  • 1 - 10

Details

Last Funding Type
Seed
Last Funding Money Raised
$1M
Industries
Biotechnology,Therapeutics
Founded date
Jan 1, 2018
Number Of Employee
1 - 10
Operating Status
Active

Myosana Therapeutics is a new biotech company developing novel platform technology for non-viral gene delivery. Myosana Therapeutics has developed a non-viral gene delivery platform technology that specifically targets muscle cells to produce the missing protein caused by a mutation of a gene.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1M
Myosana Therapeutics has raised a total of $1M in funding over 2 rounds. Their latest funding was raised on Apr 23, 2020 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 23, 2020 Seed $1M 1 CureDuchenne Ventures Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Myosana Therapeutics is funded by 1 investors. CureDuchenne Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
CureDuchenne Ventures Yes Seed